Advertisement
Advertisement
U.S. Markets closed
Advertisement
Advertisement
Advertisement
Advertisement

Puma Biotechnology, Inc. (PBYI)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
4.3500+0.0500 (+1.16%)
At close: 04:00PM EST
4.3500 0.00 (0.00%)
After hours: 04:00PM EST
Advertisement
Get access to 40+ years of historical data with Yahoo Finance Plus Essential.
Currency in USD

Valuation Measures4

Yahoo Finance Plus required to access annual data
Annual
Quarterly
Yahoo Finance Plus required to access monthly data
Monthly
Subscribe to Yahoo Finance Plus Essential to download historical data
 
As of Date: 2/1/2023
Current
Market Cap (intraday)
N/A
Enterprise Value
N/A
Trailing P/E
N/A
Forward P/E
N/A
PEG Ratio (5 yr expected)
N/A
Price/Sales (ttm)
N/A
Price/Book (mrq)
N/A
Enterprise Value/Revenue
N/A
Enterprise Value/EBITDA
N/A

Trading Information

Stock Price History

Beta (5Y Monthly) 0.64
52-Week Change 3N/A
S&P500 52-Week Change 3N/A
52 Week High 35.1600
52 Week Low 31.6000
50-Day Moving Average 34.4532
200-Day Moving Average 33.0977

Share Statistics

Avg Vol (3 month) 3419.12k
Avg Vol (10 day) 3240.58k
Shares Outstanding 540.89M
Implied Shares Outstanding 6N/A
Float 834.98M
% Held by Insiders 113.96%
% Held by Institutions 163.05%
Shares Short (Oct 13, 2022) 41.52M
Short Ratio (Oct 13, 2022) 410.61
Short % of Float (Oct 13, 2022) 44.09%
Short % of Shares Outstanding (Oct 13, 2022) 43.35%
Shares Short (prior month Sep 14, 2022) 41.77M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 30, 2021
Most Recent Quarter (mrq)Jun 29, 2022

Profitability

Profit Margin -16.67%
Operating Margin (ttm)4.44%

Management Effectiveness

Return on Assets (ttm)2.53%
Return on Equity (ttm)-140.14%

Income Statement

Revenue (ttm)206.86M
Revenue Per Share (ttm)4.89
Quarterly Revenue Growth (yoy)11.50%
Gross Profit (ttm)209.45M
EBITDA 18.39M
Net Income Avi to Common (ttm)-34.48M
Diluted EPS (ttm)-1.5160
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)60.75M
Total Cash Per Share (mrq)1.33
Total Debt (mrq)115.5M
Total Debt/Equity (mrq)585.19
Current Ratio (mrq)2.01
Book Value Per Share (mrq)-0.15

Cash Flow Statement

Operating Cash Flow (ttm)-35.71M
Levered Free Cash Flow (ttm)-22.05M
Advertisement
Advertisement